In March 2025, the company declared new strategies for a immediate-to-shopper supplying of its Wegovy weight loss drug. The company recognized a completely new pharmacy, referred to as NovoCare, which would charge customers $499 each month for entry to the drug, below half the cost of the drug via other pharmaceutical distribution networks.[53]In O